3D Biotek Appoints James W. Fay to Senior Executive Vice President Role

Share this story with your network

NORTH BRUNSWICK, N.J.–(BUSINESS WIRE)–3D Biotek announced today the appointment of James W. Fay as Senior Executive Vice President and a member of their management leadership team. In this capacity Mr. Fay will be responsible for global marketing, sales and all business development activities.

Mr. Fay brings more than 30 years of experience in the biopharma industry to his new assignment. Most recently, he held a senior position with SansRosa Development Inc., a start-up Dermatology Company that was acquired by Galderma. He currently serves as an advisor on the Galderma/SansRosa Joint Development Committee. Previously, Mr. Fay was an Executive Director with Johnson & Johnson’s (J&J) Pharmaceutical group. During his 22-year tenure at J&J, Mr. Fay held several senior level marketing positions in both operating companies and with their Global Strategic Marketing Group. Mr. Fay began his career as a sales representative for Ross Laboratories. He also worked at Wyeth and Bausch & Lomb in International Marketing.

He holds a B.A. degree from Assumption College and an M.B.A. from Widener University.

About 3D Biotek

Founded in April 2007, 3D Biotek LLC is a biotechnology company located in New Jersey, USA. Using its Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Technology, 3D Biotek is a leader in the research and development of novel 3-dimensional (3D) cell culture devices for stem cell/tissue engineering and drug discovery applications.

The first product line commercialized by 3D Biotek is the 3D InsertTM, a series of novel 3D porous scaffolds for use in drug screening, stem cell research, and tissue engineering. The application of these 3D InsertTM enables researchers to create superior in vitro models to obtain more realistic physiological results from in vitro studies. As a result, the use of 3D cell culture will decrease the overall therapeutic and pharmaceutical product development cost and shorten the time to market.

In April 2010, through 3D Biotek’s collaboration with BioCellChallenge, a French company specializing in intracellular delivery systems, the world’s only 3D Cell Transfection Kit was made available to researchers worldwide.

3D Biotek is further developing additional novel products and technologies to overcome current challenges in multiple medical fields, such as orthopedic and angioplasty field, as well as offering services to customers who need to fabricate custom biomedical devices.

Leave a Comment

Your email address will not be published. Required fields are marked *

*